Atogepant and its Place in the Migraine Treatment Landscape
Lawrence Severt, MD, PhD, discussed the history of CGRP antagonists and what atogepant can potentially bring to the market pending approval.
Seizure Exacerbation Not Observed in People With Epilepsy and COVID-19
Researchers could not identify any risk factors for contracting COVID-19 in the population with epilepsy.
Funding Research in Progressive MS: Kathy Zackowski, PhD, OTR
The senior director of patient management, care, and rehabilitation research at the National Multiple Sclerosis Society discussed the importance of fundraising events to further MS research.
FDA Approves IND for Ketamine in Parkinson Disease Dyskinesia
An upcoming phase 2 trial will assess ketamine in up to 36 patients, using change in the Unified Dyskinesia Rating Scale as the primary end point of the study.
Investigating Disparities in Post-Stroke Rehabilitation
Sana Somani, MD, MBBS, vascular neurology fellow at the University of Maryland Medical Center, discussed her research into disparities in post-stroke care.
Imaging Demonstrates Ocrelizumab’s Impact in Progressive MS: Robert Zivadinov, MD, PhD
The professor of neurology and director of the Buffalo Neuroimaging Analysis Center discussed his work on the ORATORIO study.
This Week on NeurologyLive — May 24, 2021
Here's what is coming soon to NeurologyLive.
Improving Post-Stroke Mobility With the IpsiHand Stroke Rehab System: Eric Leuthardt, MD
The founder and chief scientific officer of Neurolutions discussed the clinical tools that make up the IpsiHand Upper Extremity Rehabilitation System and the benefits it brings.
MedRhythms, Massachusetts General Hospital to Assess Auditory Stimulation Therapeutic for MS Gait Impairment
The trial will be the first neuroimaging study aimed at observing the impacts of rhythmic auditory stimulation on walking impairment in multiple sclerosis.
Patients With Chronic Migraine More Likely to Face Barriers to Successful Migraine Care
A recent paper supported by several presentations at AAN 2021 elucidate areas of migraine care to improve.
Monitoring Progression in Multiple Sclerosis: Stephen Rao, PhD, ABPP-Cn
The Ralph and Luci Schey Chair and Director of the Schey Center for Cognitive Neuroimaging at Cleveland Clinic discussed his investigations into improving the MSPT.
All-Cause Dementia, Alzheimer Disease Are Independent Risk Factors for COVID-19 Severity, Death
The findings suggest that patients with dementia should be prioritized for stringent preventive measures, greater surveillance, and early intervention in COVID-19.
ET Associated With Substantial HCRU, MS Phenotypes Share Common Mechanisms, Hypertension Risk in Menopausal Women With Migraine
Neurology News Network for the week ending May 22, 2021.
Finding a Cure for Multiple Sclerosis: Kathy Zackowski, PhD, OTR
The senior director of patient management, care, and rehabilitation research at the National MS Society discussed the organization’s ultimate goal of curing MS.
NeurologyLive Friday 5 — May 21, 2021
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 21, 2021.
Improving Post-Stroke Outcomes With Personalized Discharge Instructions
Marian LaMonte, MD, MSN, FAAN, chief of neurology at Ascension Saint Agnes, discussed her team’s efforts to improve compliance in providing stroke discharge instructions.
Underutilization of Preventive Migraine Treatments: Stephanie J. Nahas, MD
The associate professor and director of the Headache Medicine Fellowship Program at Thomas Jefferson University discussed the barriers to the use of preventive medicines.
Factors of Premature Mortality Disparities Due to Stroke Identified
The county with the highest premature stroke mortality was 20.78 times higher than that of the county with the lowest mortality. The data have raised alarms among the study authors.
Episode 37: The Impact of Awareness Efforts in ALS
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Matthew B. Harms, MD.
Patients With Essential Tremor Experience High Economic Burden
A budget impact analysis suggested that Cala Health’s Cala Trio device can serve as a cost-saving treatment option for patients with ET.
Relapsing and Progressive MS Both Impacted by Environmental and Lifestyle Factors
Environmental factors such as smoking, alcohol consumption, overweight/obese status, and sun exposure were associated with an increased risk of relapsing-onset and progressive-onset MS.
Correcting Practice Effects on the MSPT: Stephen Rao, PhD, ABPP-Cn
The Ralph and Luci Schey Chair and Director of the Schey Center for Cognitive Neuroimaging at Cleveland Clinic discussed the importance of correcting practice effects to determine performance.
MS Care Experienced Profound Changes During COVID-19 Pandemic
Only 4.9% of respondents in active clinical practice at the time of the survey reported not using telehealth when providing patient care services.
Expanding Accessibility of MANAGE-PD Screening Tool: Hubert Fernandez, MD
The director of the Center for Neurological Restoration at Cleveland Clinic discussed future ideas for the MANAGE-PD tool to furthering its benefits.
Reevaluating Prevalence and Management of Generalized Epilepsy in Elders
Vineet Punia, MD, MS, shared thoughts on his study from AAN 2021 which characterized generalized epilepsy in older adults and the elderly, and raised questions about its overall prevalence.
The Ever-Expanding Multiple Sclerosis Therapeutics
Join Ahmed Obeidat, MD, PhD; Mitchell Freedman, MD; and Suma Shah, MD, for the second program of this monthly series as they discuss the evolution of therapeutics for the treatment of multiple sclerosis.
Assessing Accuracy in Teleneurology for Stroke Consultations
Jason Poon, MD, neurologist at University of Utah, discussed his study on diagnostic accuracy in telestroke consultations.
Study Design for Phase 3 PHOENIX Trial for AMX0035 in ALS Announced
The trial design was presented at the 2021 ENCALS meeting and is set to run for 48 weeks at more than 50 clinical centers.
Atrophied Lesion Volume as Biomarker in Progressive MS: Robert Zivadinov, MD, PhD
The professor of neurology and director of the Buffalo Neuroimaging Analysis Center discussed the development of the aT2-LV biomarker.
Hypertension Risk Elevated in Menopausal Women With Migraine
Migraine with aura was associated with the risk of incident hypertension and no significant difference was observed between individuals with or without aura.